MRNA Free Cash Flow
Operating cash flow less capital expenditures — the cash a business keeps after funding itself.
Latest Free Cash Flow: -$563M (2026Q2); +38.9% YoY.
Across the 14 quarters from 2023Q1 to 2026Q2, Free Cash Flow ranged from -$1.74B in 2023Q3 to $891M in 2025Q4.
MRNA Free Cash Flow
Latest: -$563M (2026Q2)
Healthcare Comparison
1 / 3
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 6
Revenue
EPS
Gross Margin
FCF Margin
Cumulative FCF
Rule of 40